Psilox

Reference number
Coordinator BIOMATCELL AB
Funding from Vinnova SEK 2 000 000
Project duration May 2013 - December 2014
Status Completed

Purpose and goal

The project aimed to develop a business plan, regulatory strategy, manufacturing strategy, protect technology with IPR and prove the mode-of-action in the clinic. The goal was to create a base for future commercialization. These aspects have been investigated during the project and all of them except one clinical study has been carried out. For the future, the technology has now been placed in a company and a first new emission of shares has been filled and will be completed shortly.

Results and expected effects

The outcome for the project is that a new company has been created with the basis from the documents and information gained under VinnVeriferingsprojektet. The company has now secured a first investment and will be able to start implementing the business plan.

Approach and implementation

The set-up to work toward milestones have been good for the project when the focus of each part has guided project for business development, process development and proof of the technology in key tests.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2013-01089

Page statistics